Navigator Medicines
Scotch Plains, US · Founded 2024 · Delaware corporation · 2 known investors
Find your way into Navigator Medicines
Sign up to see every warm intro you have to Navigator Medicines
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Navigator Medicines team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Develops antibodies for treating autoimmune diseases.
Founders & leadership
NM
NAVEEN MANU DARYANIExecutive
TB
TAUSIF BUTTExecutive
SF
SCOTT FORRESTExecutive
SB
STEPHEN BASIL THOMASNamed on SEC filing
WD
WILLIAM DALEY BONIFICIONamed on SEC filing
Board
AL

WJ

MV
MATHIAS VINTHERBoard director
KF
KHUREM FAROOQBoard director
Investors · 2
ForbionreportedNaardenvia Wouter Joustra · board
How we know: a partner's Signal profile · board seat on SEC Form D · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$60M disclosed across 2 rounds · 2024–2026
▶$10MraisedSep 2026 · 3 investors · BiotechnologyRule 506(b)
▶$10MraisedSep 2026 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- TAUSIF BUTTExecutive Officer, Director, Promoter
- STEPHEN BASIL THOMASExecutive Officer, Director, Promoter
- SCOTT FORRESTExecutive Officer
- WOUTER JOUSTRADirector
- KHUREM FAROOQDirector
- MATHIAS VINTHERDirector
- KRISTIE GREBEExecutive Officer
- Offering amount
- $40M
- Amount sold
- $10M
- First sale
- Sep 2026
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
▶$50MraisedSep 2024 · 4 investors · BiotechnologyRule 506(b)
▶$50MraisedSep 2024 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- NAVEEN MANU DARYANIExecutive Officer
- ANDREW LEVINDirector
- STEPHEN BASIL THOMASExecutive Officer, Director, Promoter
- WILLIAM DALEY BONIFICIOExecutive Officer, Promoter
- WOUTER JOUSTRADirector
- Offering amount
- $100M
- Amount sold
- $50M
- First sale
- Aug 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Navigator Medicines do?
- Develops antibodies for treating autoimmune diseases.
- Who are Navigator Medicines's investors?
- Navigator Medicines's investors include RA Capital, Forbion.
- How much funding has Navigator Medicines raised?
- Navigator Medicines has disclosed $60M raised across 2 rounds.
- Where is Navigator Medicines headquartered?
- Navigator Medicines is headquartered in Scotch Plains, US.
